Metformin, a chemical relative of that compound, has been a top type 2 diabetes treatment in the United States since it was approved in 1994. It’s cheap—less than a dollar per dose—and readily ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

Medicare coverage of weight loss drugs, if authorized, would increase federal spending by about $35B from 2026 to 2034, ...

The State Health Plan's decision to end coverage of certain weight-loss prescription drugs has produced an unlikely and ...

Eli Lilly and Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, ...

Compounded versions of popular weight-loss drugs attracted telehealth companies that marketed services to connect patients ...

Health experts are now looking at whether semaglutide can also curb alcohol cravings among addicts. A look at how this GLP-1 ...

The Food and Drug Administration on Friday approved Regeneron Pharmaceuticals and Sanofi ... which includes medicines for cancer, obesity and another Sanofi-partnered drug, itepekimab, that’s in ...

WASHINGTON, 28th September, 2024 (WAM) -- The US Food and Drug Administration (FDA) has approved French pharmaceutical company Sanofi's Dupixent, an anti-bronchitis drug for smokers. According to the ...

World No1 Jannik Sinner could now face a ban of up to two years after his steroid case was appealed by the World Anti-Doping Agency. WADA said it is seeking a ban of one to two years for the US ...

A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...